EUVIMEDEUVIMED entdecken
Crossref

Regulation of the DDAH/ADMA/NO axis by miR-193a and miR-939-5p in triple-negative breast cancer

Malak Ibrahim, Heba Nafea, Reham M. Abdel-Kader, Rana A. Youness, Mohamed Z. Gad

Eurasian Journal of Medicine and Oncology · 24.07.2026 · 026160184

DOI: 10.36922/ejmo026160184 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Eurasian Journal of Medicine and Oncology, online erschienen am 24.07.2026. Verfasst von Malak Ibrahim und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dysregulated nitric oxide (NO) signaling plays a role in the viciousness of triple-negative breast cancer (TNBC). Dimethylarginine dimethylaminohydrolase 1 (DDAH1), which hydrolyzes asymmetric dimethylarginine (ADMA), an endogenously produced inhibitor of nitric oxide synthase (NOS), enhances NO production and promotes tumor vascularization, linking it to tumor progression. However, the roles of DDAH1 and its isoform DDAH2, and their regulation in the DDAH/ADMA/NO axis, remain poorly defined. Given their emerging role in gene regulation, microRNAs (miRNAs) may offer novel approaches for modulating this pathway in TNBC.

Objective

To investigate the regulatory effects of miR-939-5p and miR-193a on the DDAH/ADMA/NO axis in TNBC.

Methods

RNA was extracted from breast cancer (BC) tissues, and MDA-MB-231 TNBC cells were subjected to miRNA mimics. Gene expression was analyzed by quantitative reverse transcription-polymerase chain reaction, ADMA levels were quantified using a competitive enzyme-linked immunosorbent assay, and NO levels were measured with the Griess assay.

Results

DDAH1, but not DDAH2, expression was elevated in BC samples. Overexpression of either miR-939-5p or miR-193a suppressed DDAH1 and DDAH2 in TNBC cells, elevating ADMA levels and reducing NO bioavailability. In addition, overexpression of miR-193a directly influenced NOS2 and NOS3 transcripts, further suppressing NO synthesis. These dual effects highlight the capacity of miRNAs to regulate NO signaling at multiple levels.

Conclusion

This study highlighted the overexpression of DDAH1 in 20 Egyptian BC patients, a previously underexplored area. Moreover, it provided the first evidence that miR-939-5p and miR-193a modulate the ADMA/NO pathway in TNBC. This was achieved by simultaneously suppressing DDAH1/DDAH2 and NOS enzymes; the miRNAs shifted the balance toward ADMA accumulation and reduced NO signaling. These findings identify miR-939-5p and miR-193a as novel regulators of the DDAH/ADMA/NO axis in TNBC and provide new insights into the molecular mechanisms governing this pathway.

Zitieren

APA

Ibrahim, M., Nafea, H., Abdel-Kader, R. M., Youness, R. A., & Gad, M. Z. (2026). Regulation of the DDAH/ADMA/NO axis by miR-193a and miR-939-5p in triple-negative breast cancer. Eurasian Journal of Medicine and Oncology, 0(0), 026160184. https://doi.org/10.36922/ejmo026160184

Vancouver

Ibrahim M, Nafea H, Abdel-Kader RM, Youness RA, Gad MZ. Regulation of the DDAH/ADMA/NO axis by miR-193a and miR-939-5p in triple-negative breast cancer. Eurasian Journal of Medicine and Oncology. 2026;0(0):026160184. doi:10.36922/ejmo026160184

BibTeX
@article{Ibrahim2026,
  author = {Ibrahim, Malak and Nafea, Heba and Abdel-Kader, Reham M. and Youness, Rana A. and Gad, Mohamed Z.},
  title = {Regulation of the DDAH/ADMA/NO axis by miR-193a and miR-939-5p in triple-negative breast cancer},
  journal = {Eurasian Journal of Medicine and Oncology},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026160184},
  doi = {10.36922/ejmo026160184}
}
Kostenlos starten →